You are here

  • Home
  • Archive
  • Volume 19, Issue 6
  • Phase II Study of Pegylated Liposomal Doxorubicin and Carboplatin in Patients With Platinum-Sensitive and Partially Platinum-Sensitive Metastatic Ovarian Cancer

Article metrics

Article menu
Download PDFPDF
Original Articles: Chemotherapy
Phase II Study of Pegylated Liposomal Doxorubicin and Carboplatin in Patients With Platinum-Sensitive and Partially Platinum-Sensitive Metastatic Ovarian Cancer

 

Online download statistics by month:

Online download statistics by month: March 2019 to October 2024

AbstractFullPdf
Mar 20197402
Apr 20198301
May 20192600
Jun 20191000
Jul 20191100
Aug 20193000
Sep 20191900
Oct 2019601
Nov 2019600
Dec 2019600
Jan 20201800
Feb 20201000
Mar 2020700
Apr 2020700
May 20201200
Jun 20201600
Jul 20201401
Aug 20202200
Sep 20202500
Oct 2020800
Nov 2020200
Dec 20201000
Jan 20211700
Feb 2021700
Mar 20211000
Apr 2021400
Aug 2021100
Oct 20211000
Nov 20212400
Dec 20211000
Jan 20221000
Feb 2022600
Mar 20221400
Apr 20221000
May 20223500
Jun 20224000
Jul 20223400
Aug 20223800
Sep 20223600
Oct 20225300
Nov 20222401
Dec 20222800
Jan 20231300
Feb 20235901
Mar 20231001
May 20231202
Jun 2023400
Jul 2023600
Aug 2023800
Sep 2023200
Oct 20232000
Nov 2023700
Dec 20231000
Jan 20241400
Feb 20241800
Mar 20241200
Apr 20241700
May 20241800
Jun 20241200
Jul 20242500
Aug 20242000
Sep 2024700
Oct 2024200
Total1129010